IDEX: Health & Science Division History
Former Senior Executive at IDEX Health & Science
inpractise.com/articles/idex-health-and-science-history
IDEX: Health & Science Division History(April 1, 2025)
Former Senior Executive at IDEX Health & Science
Interview Transcript
This is a snippet of the transcript, sign up to read more.
How is 80/20 applied? I can see if you're combining businesses and running a bigger business that it's easier, probably, in the end, to apply 80/20. But when you've got lots of little businesses, how do you apply it? And it's so decentralized and quite autonomous.
The short answer is you apply it per rooftop or per individual business. You perform a product and customer analysis for each business, graphing and tabulating all the data around customer products and the margins they represent. Then, you categorize them into the four quadrants of the 80/20 analysis.
This is a snippet of the transcript, sign up to read more.
How is 80/20 applied? I can see if you're combining businesses and running a bigger business that it's easier, probably, in the end, to apply 80/20. But when you've got lots of little businesses, how do you apply it? And it's so decentralized and quite autonomous.
Quadrant one customers are the ones you definitely keep. Quadrant four customers are those you're willing to let go. There's a subset of customers you hold onto but increase pricing for, and another set that are necessary evils you must keep for various reasons. This analysis is done by rooftop and is relatively straightforward, with clear definitions and KPIs to ensure correct analysis.
This is a snippet of the transcript, sign up to read more.
Related Content
IDEX Corporation: Culture & the 80/20 Principle
Former VP at Idex Corporation
IDEX Corporation: M&A strategy & Operating model
Former Idex Corporation President
Graco: Culture, Sales, & Distribution
Former Global Vice President at Graco
Danaher Business System: Hach Sales Team Case Study
Former VP at Danaher
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.